Clinical trial
The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
NCT00451672 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00451672 |
|---|---|
| Title | The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyperaldosteronism, Hypertension |
| Intervention type | Drug |
| Interventions | bromocriptine |
| Enrollment | 25 |
| Start date | Jan 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Mar 23, 2007 |
| Last update posted | Mar 23, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: